Patients with GBM exhibited a significantly lower frequency of CD3+/CD4+ T cells than that in the healthy control (median values of 39.5% (GBM) versus 47.9% (healthy donors), ** p < 0.001). The gene discussed is CD4; the disease is glioblastoma.